Chengdu Kanghong Biotechnology Co., Ltd. et al. v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2021-00402
Filing Date Jan 7, 2021
Institution Decision Date -
Decision Date Jun 25, 2021
Court Patent Trial and Appeal Board
Status Terminated
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
Patent Owner
Petitioner Attorneys
3Patent Owner Attorneys
6Regeneron Pharmaceuticals
Attorney Name: David A. Caine
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Joshua D. Seitz
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Victoria Reines
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Rebecca L. Neubauer
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Matthew Wilk
Arnold & Porter Kaye Scholer
Related Patents
Doc No | Title | Issue date |
---|---|---|
10464992 | VEGF antagonist formulations suitable for intravitreal administration | Nov 5, 2019 |